Q2 2023 Holdings
Filed 2023-08-14 | 122 holdings | $627.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acelyrin Inc | COM | 00445A100 | $61.0M | 2,918,426 | 9.7% |
| Argenx SE(ARGX)Put | SPONSORED ADR | 04016X101 | $51.5M | 132,100 | 8.2% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $21.2M | 1,229,800 | 3.4% |
| Biomea Fusion Inc(BMEA)Call | COM | 09077A106 | $20.6M | 936,800 | 3.3% |
| TG Therapeutics Inc(TGTX)Call | COM | 88322Q108 | $20.5M | 826,100 | 3.3% |
| TG Therapeutics Inc(TGTX)Put | COM | 88322Q108 | $20.5M | 826,100 | 3.3% |
| Astrazeneca PLC(AZN)Call | SPONSORED ADR | 046353108 | $17.9M | 250,000 | 2.8% |
| Argenx SE(ARGX)Call | SPONSORED ADR | 04016X101 | $14.8M | 38,000 | 2.4% |
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $14.0M | 122,100 | 2.2% |
| Ventyx Biosciences Inc(VTYX)Put | COM | 92332V107 | $12.3M | 374,100 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $12.2M | 133,800 | 1.9% |
| Apellis Pharmaceuticals Inc(APLS)Put | COM | 03753U106 | $12.1M | 133,000 | 1.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $11.5M | 100,000 | 1.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $11.5M | 490,893 | 1.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $11.5M | 272,752 | 1.8% |
| Crispr Therapeutics AG(CRSP)Put | NAMEN AKT | H17182108 | $11.2M | 200,000 | 1.8% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $11.2M | 200,000 | 1.8% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $11.2M | 110,000 | 1.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $10.7M | 240,031 | 1.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $10.2M | 485,000 | 1.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $10.2M | 427,417 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN)Put | COM | 09061G101 | $8.7M | 100,000 | 1.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $8.6M | 475,000 | 1.4% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $8.4M | 447,700 | 1.3% |
| Aclaris Therapeutics Inc(ACRS)Put | COM | 00461U105 | $8.3M | 796,300 | 1.3% |
| Replimune Group Inc(REPL)Put | COM | 76029N106 | $8.1M | 348,200 | 1.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.4M | 429,686 | 1.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.0M | 140,000 | 1.1% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $6.6M | 611,932 | 1.1% |
| Immunogen Inc(IMGNEUR)Call | COM | 45253H101 | $6.6M | 350,000 | 1.1% |
| Biomea Fusion Inc(BMEA)Put | COM | 09077A106 | $6.3M | 286,700 | 1.0% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $6.2M | 326,200 | 1.0% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $6.1M | 275,875 | 1.0% |
| Protagonist Therapeutics Inc(PTGX)Put | COM | 74366E102 | $5.8M | 211,400 | 0.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $5.7M | 280,000 | 0.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.6M | 121,658 | 0.9% |
| Protagonist Therapeutics Inc(PTGX)Call | COM | 74366E102 | $5.5M | 200,000 | 0.9% |
| Biohaven LTD(BHVN)Call | COM | G1110E107 | $5.4M | 225,000 | 0.9% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $5.3M | 228,300 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.2M | 135,486 | 0.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $5.2M | 203,037 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.8M | 579,390 | 0.8% |
| Legend Biotech Corp(LEGN)Call | SPONSORED ADS | 52490G102 | $4.7M | 68,800 | 0.8% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $4.6M | 130,000 | 0.7% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $4.2M | 200,000 | 0.7% |
| Arcus Biosciences Inc(RCUS)Call | COM | 03969F109 | $4.1M | 200,000 | 0.6% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $4.0M | 978,626 | 0.6% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $3.7M | 504,253 | 0.6% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $3.4M | 300,000 | 0.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $3.4M | 772,092 | 0.5% |